Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021
November 01, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
October 29, 2021 16:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference
October 12, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference
September 22, 2021 16:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors
September 14, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange
August 25, 2021 07:00 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke
August 17, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 11, 2021 17:00 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...